WO2005112631A2 - An antimicrobial construction - Google Patents
An antimicrobial construction Download PDFInfo
- Publication number
- WO2005112631A2 WO2005112631A2 PCT/GB2005/001878 GB2005001878W WO2005112631A2 WO 2005112631 A2 WO2005112631 A2 WO 2005112631A2 GB 2005001878 W GB2005001878 W GB 2005001878W WO 2005112631 A2 WO2005112631 A2 WO 2005112631A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- construction
- acid
- substrate
- composition
- antimicrobial composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/02—Sulfur; Selenium; Tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/14—Boron; Compounds thereof
Definitions
- the present invention relates to a construction comprising a substrate incorporating an activatable antimicrobial composition for use, for example, as a pad, a wipe, or as a means of dosing the composition.
- substrate used herein and in the claims is intended to include cloth, paper and other nonwoven materials as well as woven or knitted textile fabrics.
- substrate is intended to cover naturally occurring materials such as animal skins.
- Antimicrobial compositions must exhibit a range of properties to be useful. Many of these properties are as follows.
- composition should act rapidly - European standards require a contact time of five minutes.
- composition should be biocidal and not merely biostatic.
- composition should have a wide spectrum of activity against bacteria, including all Gram-positive and Gram-negative bacteria, as well as mycobacteria.
- composition should be active against all types of fungi.
- composition should be virucidal, against both enveloped and non- enveloped viruses.
- the composition should be effective in both clean and dirty conditions and be able to penetrate biofilms.
- composition should be rapidly effective against bacterial endospores.
- the mechanism of activity of the composition should not give rise to resistance.
- the composition should be of low toxicity to non-target life forms.
- composition should be adequately stable to allow ease of use and storage.
- the composition should be simple to use. 12. The effect and residue chemistry of the composition should be environmentally benign.
- the composition should remain rapidly effective down to low temperatures of around 4°C or lower. 14.
- the composition should embody an indicator of its performance. 15.
- the composition should be cost effective in use.
- It is an object of the present invention to provide a construction comprising a substrate incorporating with an activatable antimicrobial composition which exhibits most and, in specific formulations, all of the aforementioned properties.
- a substrate must retain the antimicrobial composition in a stable manner ready for use, at which time the composition can be activated, for example by wetting the substrate with water or other appropriate liquid.
- a construction comprising a substrate incorporating an activatable antimicrobial composition that includes a peroxygen donor and at least one of an acid and an acid-producing substance, the peroxygen donor being incorporated separately and in a different portion of the substrate from the other component or components of the composition.
- the peroxygen donor is incorporated separately and in a different portion of the substrate from the other components of the composition in order that the antimicrobial composition is only formed and activated once the substrate is wetted, preferably with water.
- the substrate is constructed as a laminate, such as a nonwoven laminate, comprising layers bonded together by a bonding medium which may be applied as a powder, net or sheet, the peroxygen donor being incorporated in the substrate in between different layers from the other components, or otherwise separated by application in a different zone or area of the substrate, for instance in parallel scatterings or in different parts of a scatter pattern .
- a bonding medium which may be applied as a powder, net or sheet, the peroxygen donor being incorporated in the substrate in between different layers from the other components, or otherwise separated by application in a different zone or area of the substrate, for instance in parallel scatterings or in different parts of a scatter pattern .
- the substrate comprises a nonwoven material made from cellulosic fibres, for example cotton, viscose, regenerated wood pulp cellulose or similar material.
- the material comprises fibres including at least one of polyester, polyamide, polyethylene, and polypropylene fibres.
- the fibres of the nonwoven have physical properties, for example bi-component fibres, which allow the substrate to be thermally or physically bonded or entangled in a discreet layer or web, it may be possible to dispense with all or most of the bonding medium.
- the substrate is impregnated with an oxygen-sensitive dye, such as a vat dye, which acts to indicate activity of the antimicrobial composition.
- an oxygen-sensitive dye such as a vat dye
- the acid comprises a carboxylic acid.
- the antimicrobial composition additionally incorporates an organometallic manganese containing catalyst, for example a manganese-trimethyltriazacyclononane complex.
- an organometallic manganese containing catalyst for example a manganese-trimethyltriazacyclononane complex.
- the acid may comprise a bidentate acid and preferably oxalic acid.
- Such acids can influence the nuclearity and redox potential of the metal centres in the catalyst which, in turn, improves the spectrum and speed of biocidal activity.
- other acids such as fumaric, ascorbic, succinic, glutaric and mixtures thereof may also be used.
- combinations of acid and salts of the acid may also be used, for instance, oxalic acid and sodium oxalate.
- a combination of oxalic acid and pH buffers such as sodium phosphate may also be used.
- Combinations of acids may also be used, for example a combination of oxalic acid and citric acid.
- reaction between the peroxygen donor and a bleach activator, such as tetra acetyl ethylene diamine (TAED) would beneficially produce peracetic acid.
- TAED tetra acetyl ethylene diamine
- the acid of the composition may be a separate component of the composition or may be generated in situ in the substrate on activation.
- the peroxygen donor may be chosen from any of those compounds exhibiting strong redox potential by generation of hydrogen peroxide or other mechanism.
- the peroxygen donor comprises any of sodium perborate as mono or tetra hydrate, sodium percarbonate, and sodium persulphate. It is also possible to generate an effective composition in situ by activating the substrate using a hydrogen peroxide solution.
- the substrate is preferably additionally incorporates the aforesaid organometallic manganese containing catalyst.
- the organometallic manganese containing catalyst comprises a manganese- trimethyltriazacyclononane complex, such as that known commercially as catalyst NP 1033, CAS No 116633-52-4. This is a manganese compound of the ligand ⁇ ,4,7-trimethyl-i,4,7-triazacyclononane.
- NP 1033 catalyst CAS No 116633-52-4.
- This is a manganese compound of the ligand ⁇ ,4,7-trimethyl-i,4,7-triazacyclononane.
- other manganese catalysts with related ligand structures and other biomimetic manganese containing catalysts may also be used.
- the catalyst to peroxygen donor ratio may be as high as 1:100000, however, preferably, the preferred ratio is between 1:100 and 1:3000 inclusive.
- the catalyst to acid ratio preferably when using bidentate carboxylic acid, can be in the range 1: 1 to 1: 100 but preferably the preferred ratio is between 1: 3 and 1:50 inclusive.
- compositions according to the invention may comprise one or more of anionic or nonionic surfactants such as sodium lauryl sulphate or linear alcohol ethoxylates; corrosion inhibitors, pH buffers, chelating agents or sequestrants, stabilizers, dyes, fragrances and odour masking agents.
- anionic or nonionic surfactants such as sodium lauryl sulphate or linear alcohol ethoxylates
- corrosion inhibitors such as sodium lauryl sulphate or linear alcohol ethoxylates
- corrosion inhibitors such as sodium lauryl sulphate or linear alcohol ethoxylates
- pH buffers such as sodium lauryl sulphate or linear alcohol ethoxylates
- chelating agents or sequestrants such as sodium lauryl sulphate or linear alcohol ethoxylates
- stabilizers such as sodium lauryl sulphate or linear alcohol ethoxylates
- dyes such as sodium lauryl sulphate or linear alcohol ethoxy
- Example 1 Sodium perborate tetrahydrate 1.05 parts Tetra acetyl ethylene diamine 0.014 parts Oxalic acid 0.35 parts NP 1033 O.Oi parts
- both of the formulations also show excellent sporicidal, fungicidal and virucidal properties in standard tests.
- the residue products of Example 1 are environmentally benign. It is known that in formulations containing peroxygen donors and bleach activators such as TAED that a very wide range of ratios of the two components can be used determined by requirements such as the concentration of peracetic acid generated, the rate of generation, the pH of the system, the stability, solubility and other factors. Hence in constructions in accordance with this invention a wide range of ratios of the antimicrobial composition and quantitative loadings of the substrate is possible.
- This formulation excludes the bleach accelerator. It also passes the European suspension test EN 1276: 1997 for all test organisms at a temperature of 20°C but not at a temperature of 4°C. Hence although useful, it may have more limited applications than other formulations of the composition. A change in the oxidation state of the manganese catalyst where used in these formulations is also accompanied by a colour change. These formulations therefore embody an indicator of their performance.
- the components of the antimicrobial composition are preferably produced in the form of powders or granules for ease of incorporation into separate portions of the body of the substrate, as described above, in order that the construction can remain in a stable condition ready for use.
- the antimicrobial composition can be activated by wetting the substrate with water. Such wetting may occur when a wipe construction according to the invention is wetted or is used to wipe a wet or damp surface; or is used to absorb a spillage containing an aqueous component; or is used as a filter for water which may be contaminated; or is moistened by water vapour, perspiration or other means.
- Three embodiments of construction in accordance with the present invention are as follows.
- Embodiment l The substrate comprises a nonwoven laminate construction comprising two layers of hydroentangled nonwoven containing viscose and polyester fibres separated by a thermoplastic bonding medium in sheet form.
- the layer between the bottom nonwoven and the bonding medium contains the peroxygen donor.
- the layer between the bonding medium and the top nonwoven contains the tetra acetyl ethylene diamine, surfactant, acid and other components of the antimicrobial composition.
- the chemical components of the formulation being present at quantitative levels and in such ratios and at such a pH as to generate levels of peracetic acid when the substrate is wetted, which levels of peracetic acid are appropriate to the biocidal task required.
- the substrate comprises a nonwoven laminate construction as described above in Embodiment l but wherein the bonding medium is a low melting point thermoplastic powder and the peroxygen donor component of the formulation is separated from the other components by virtue of being applied by scattering or other means which ensure the peroxygen donor powder is restricted to areas of the substrate not covered by other components with which it might react.
- the bonding medium is a low melting point thermoplastic powder and the peroxygen donor component of the formulation is separated from the other components by virtue of being applied by scattering or other means which ensure the peroxygen donor powder is restricted to areas of the substrate not covered by other components with which it might react.
- the substrate comprises a nonwoven laminate construction made up of highly absorbent airlaid fibres as one of the nonwoven layers, in which the peroxygen donor is sodium perborate monohydrate present at 15 g per square metre.
- the other components of the antimicrobial composition which include TAED present at 8.0 g per square metre, are separated by virtue of two discreet patterns of powder scattering in combination with a thermoplastic powder bonding adhesive.
- the complete construction, on wetting, is capable of generating sooppm of peracetic acid in one litre of water.
Abstract
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0510827-6A BRPI0510827A (en) | 2004-05-21 | 2005-05-18 | an antimicrobial construction |
EP05744426A EP1755387B1 (en) | 2004-05-21 | 2005-05-18 | An antimicrobial construction |
ES05744426T ES2396554T3 (en) | 2004-05-21 | 2005-05-18 | An antimicrobial construction |
US11/569,417 US20080160057A1 (en) | 2004-05-21 | 2005-05-18 | Antimicrobial Construction |
CA2567473A CA2567473C (en) | 2004-05-21 | 2005-05-18 | An antimicrobial construction |
AU2005244642A AU2005244642B2 (en) | 2004-05-21 | 2005-05-18 | An antimicrobial construction |
CN2005800162715A CN1960630B (en) | 2004-05-21 | 2005-05-18 | antibacterial structure |
JP2007517406A JP4842935B2 (en) | 2004-05-21 | 2005-05-18 | Antimicrobial construct |
HK07112303.0A HK1106980A1 (en) | 2004-05-21 | 2007-11-09 | An antimicrobial construction |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0411304.9A GB0411304D0 (en) | 2004-05-21 | 2004-05-21 | An antimicrobial composition |
GB0411304.9 | 2004-05-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005112631A2 true WO2005112631A2 (en) | 2005-12-01 |
WO2005112631A3 WO2005112631A3 (en) | 2006-03-09 |
Family
ID=32607686
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2005/001878 WO2005112631A2 (en) | 2004-05-21 | 2005-05-18 | An antimicrobial construction |
PCT/GB2005/001900 WO2005112647A2 (en) | 2004-05-21 | 2005-05-18 | An antimicrobial composition |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2005/001900 WO2005112647A2 (en) | 2004-05-21 | 2005-05-18 | An antimicrobial composition |
Country Status (11)
Country | Link |
---|---|
US (1) | US20080160057A1 (en) |
EP (1) | EP1755387B1 (en) |
JP (1) | JP4842935B2 (en) |
CN (1) | CN1960630B (en) |
AU (1) | AU2005244642B2 (en) |
BR (1) | BRPI0510827A (en) |
CA (1) | CA2567473C (en) |
ES (1) | ES2396554T3 (en) |
GB (1) | GB0411304D0 (en) |
HK (1) | HK1106980A1 (en) |
WO (2) | WO2005112631A2 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010022919A1 (en) * | 2008-08-30 | 2010-03-04 | Clariant International Ltd | Bleach catalyst mixtures consisting of manganese salts and oxalic acid or the salts thereof |
US8293910B2 (en) | 2008-08-19 | 2012-10-23 | Clariant Finance (Bvi) Limited | Method for producing 3,7-diaza-bicyclo[3.3.1]nonane compounds |
US8536334B2 (en) | 2008-12-19 | 2013-09-17 | Clariant Finance (Bvi) Limited | Method for producing 3,7-diaza-bicyclo[3.3.1]nonane metal complexes |
US8927478B2 (en) | 2008-08-30 | 2015-01-06 | Clariant International Ltd. | Use of manganese oxalates as bleach catalysts |
WO2018020190A1 (en) | 2016-07-28 | 2018-02-01 | Laboratoires Anios | Two-part cleaning and/or disinfecting system |
US20180207105A1 (en) * | 2014-04-01 | 2018-07-26 | Aga Nanotech Ltd | Method for manufacturing a therapeutic agent for use in the treatment of infections |
WO2019034747A1 (en) * | 2017-08-16 | 2019-02-21 | Ceva Sante Animale | New disinfectant for hatcheries |
US10300162B2 (en) | 2014-10-07 | 2019-05-28 | Peracide (Uk) Limited | Disinfectant wipe dispenser |
US10660338B2 (en) | 2014-01-14 | 2020-05-26 | Peracide (Uk) Limited | Sporocidal disinfectant or sanitising composition |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9573828B2 (en) * | 2012-05-07 | 2017-02-21 | Dmr International, Inc. | Liquid purification system |
US9580334B2 (en) * | 2013-05-05 | 2017-02-28 | Dmr International, Inc. | Liquid purification system |
US20170215412A2 (en) | 2013-11-11 | 2017-08-03 | Whiteley Corporation Pty. Ltd. | Disinfectant Composition |
US9717817B2 (en) | 2013-12-30 | 2017-08-01 | International Paper Company | Binary odor control system for absorbent articles |
US10280386B2 (en) | 2015-04-03 | 2019-05-07 | Ecolab Usa Inc. | Enhanced peroxygen stability in multi-dispense TAED-containing peroxygen solid |
US9783766B2 (en) | 2015-04-03 | 2017-10-10 | Ecolab Usa Inc. | Enhanced peroxygen stability using anionic surfactant in TAED-containing peroxygen solid |
EP3810743B1 (en) | 2018-06-15 | 2024-03-13 | Ecolab USA Inc. | Enhanced peroxygen stability using fatty acid in bleach activating agent containing peroxygen solid |
KR102170702B1 (en) * | 2019-09-05 | 2020-10-27 | (주)피치켐 | Disinfectant composition including citric acid and catalase |
CN110966125A (en) * | 2019-10-22 | 2020-04-07 | 四会市新亚商绿环保科技有限公司 | Air inlet filter screen, automobile energy-saving air grid and preparation method thereof |
GB2592911B (en) * | 2020-02-28 | 2023-06-28 | Aga Nanotech Ltd | A plasma-activatable wound dressing for treatment of infections |
GB202005556D0 (en) | 2020-04-16 | 2020-06-03 | Aga Nanotech Ltd | Covid face mask |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6210639B1 (en) | 1998-10-26 | 2001-04-03 | Novartis Ag | Apparatus, method and composition for cleaning and disinfecting |
WO2002058748A1 (en) | 2001-01-26 | 2002-08-01 | Camelot Technologies Limited | Absorbent pad for rendering hazardous liquids non-hazardous |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5374394A (en) * | 1986-02-06 | 1994-12-20 | Steris Corporation | Medical waste decontamination |
US5407685A (en) * | 1986-02-06 | 1995-04-18 | Steris Corporation | Controlled oxygen/anti-microbial release films |
GB8819969D0 (en) * | 1988-08-23 | 1988-09-21 | Fibre Treatments Holdings Ltd | Disinfecting/bleaching tissue |
GB9108136D0 (en) * | 1991-04-17 | 1991-06-05 | Unilever Plc | Concentrated detergent powder compositions |
US5720896A (en) * | 1992-06-02 | 1998-02-24 | The Procter & Gamble Company | Laundry bleaching composition |
GB9415906D0 (en) * | 1994-08-05 | 1994-09-28 | Warwick Int Group | Oxidising compositions |
DE19512588A1 (en) * | 1995-04-04 | 1996-10-10 | Bode Chemie Gmbh & Co | Instrument disinfectants |
JPH09140647A (en) * | 1995-11-29 | 1997-06-03 | Sekisui Chem Co Ltd | Washing tool for sterilization and bleaching |
AUPO371096A0 (en) * | 1996-11-18 | 1996-12-12 | Green, Bruce Phillip | Corrosion inhibiting composition |
DE19710370A1 (en) * | 1997-03-13 | 1998-09-17 | Henkel Kgaa | Use of cage metal-enclosed transition metal complexes to enhance coverage |
JPH10324895A (en) * | 1997-03-21 | 1998-12-08 | Lion Corp | Mildew removal agent composition |
JPH10279412A (en) * | 1997-03-31 | 1998-10-20 | Lion Corp | Mildew-removing agent composition |
JPH1161191A (en) * | 1997-08-07 | 1999-03-05 | Lion Corp | Mold removing agent composition |
JPH11166196A (en) * | 1997-12-04 | 1999-06-22 | Lion Corp | Mold removal agent composition |
JPH11335693A (en) * | 1998-05-28 | 1999-12-07 | Lion Corp | Granular fungus-removing agent composition |
JP2000073095A (en) * | 1998-08-28 | 2000-03-07 | Lion Corp | Mold removing composition |
GB2355198A (en) * | 1999-05-06 | 2001-04-18 | Medichem Internat Ltd | An aldehyde-free sterilant and disinfectant based on a peroxide source in powder or kit form for mixing and/or diluting |
US20030139310A1 (en) * | 2001-08-07 | 2003-07-24 | Smith Kim R. | Peroxygen compositions and methods for carpet or upholstery cleaning or sanitizing |
US7192554B2 (en) * | 2001-12-31 | 2007-03-20 | 3M Innovative Properties Company | Hydrogen peroxide and peracetic acid indicators and methods |
RU2224547C1 (en) * | 2002-07-24 | 2004-02-27 | Канищев Владимир Васильевич | Sporocide disinfecting agent |
-
2004
- 2004-05-21 GB GBGB0411304.9A patent/GB0411304D0/en not_active Ceased
-
2005
- 2005-05-18 EP EP05744426A patent/EP1755387B1/en active Active
- 2005-05-18 ES ES05744426T patent/ES2396554T3/en active Active
- 2005-05-18 WO PCT/GB2005/001878 patent/WO2005112631A2/en active Application Filing
- 2005-05-18 CA CA2567473A patent/CA2567473C/en active Active
- 2005-05-18 CN CN2005800162715A patent/CN1960630B/en active Active
- 2005-05-18 BR BRPI0510827-6A patent/BRPI0510827A/en not_active IP Right Cessation
- 2005-05-18 US US11/569,417 patent/US20080160057A1/en not_active Abandoned
- 2005-05-18 JP JP2007517406A patent/JP4842935B2/en active Active
- 2005-05-18 AU AU2005244642A patent/AU2005244642B2/en active Active
- 2005-05-18 WO PCT/GB2005/001900 patent/WO2005112647A2/en active Application Filing
-
2007
- 2007-11-09 HK HK07112303.0A patent/HK1106980A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6210639B1 (en) | 1998-10-26 | 2001-04-03 | Novartis Ag | Apparatus, method and composition for cleaning and disinfecting |
WO2002058748A1 (en) | 2001-01-26 | 2002-08-01 | Camelot Technologies Limited | Absorbent pad for rendering hazardous liquids non-hazardous |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8293910B2 (en) | 2008-08-19 | 2012-10-23 | Clariant Finance (Bvi) Limited | Method for producing 3,7-diaza-bicyclo[3.3.1]nonane compounds |
WO2010022919A1 (en) * | 2008-08-30 | 2010-03-04 | Clariant International Ltd | Bleach catalyst mixtures consisting of manganese salts and oxalic acid or the salts thereof |
US8927478B2 (en) | 2008-08-30 | 2015-01-06 | Clariant International Ltd. | Use of manganese oxalates as bleach catalysts |
US8536334B2 (en) | 2008-12-19 | 2013-09-17 | Clariant Finance (Bvi) Limited | Method for producing 3,7-diaza-bicyclo[3.3.1]nonane metal complexes |
US10660338B2 (en) | 2014-01-14 | 2020-05-26 | Peracide (Uk) Limited | Sporocidal disinfectant or sanitising composition |
US20180207105A1 (en) * | 2014-04-01 | 2018-07-26 | Aga Nanotech Ltd | Method for manufacturing a therapeutic agent for use in the treatment of infections |
US10933026B2 (en) * | 2014-04-01 | 2021-03-02 | Aga Nanotech Ltd | Method for manufacturing a therapeutic agent for use in the treatment of infections |
US10300162B2 (en) | 2014-10-07 | 2019-05-28 | Peracide (Uk) Limited | Disinfectant wipe dispenser |
WO2018020190A1 (en) | 2016-07-28 | 2018-02-01 | Laboratoires Anios | Two-part cleaning and/or disinfecting system |
WO2019034747A1 (en) * | 2017-08-16 | 2019-02-21 | Ceva Sante Animale | New disinfectant for hatcheries |
US11917998B2 (en) | 2017-08-16 | 2024-03-05 | Ceva Sante Animale | Disinfectant for hatcheries |
Also Published As
Publication number | Publication date |
---|---|
AU2005244642B2 (en) | 2010-04-29 |
AU2005244642A1 (en) | 2005-12-01 |
CN1960630A (en) | 2007-05-09 |
EP1755387B1 (en) | 2012-11-28 |
EP1755387A2 (en) | 2007-02-28 |
HK1106980A1 (en) | 2008-03-28 |
JP2007538059A (en) | 2007-12-27 |
CN1960630B (en) | 2011-12-07 |
ES2396554T3 (en) | 2013-02-22 |
JP4842935B2 (en) | 2011-12-21 |
GB0411304D0 (en) | 2004-06-23 |
US20080160057A1 (en) | 2008-07-03 |
WO2005112647A2 (en) | 2005-12-01 |
CA2567473C (en) | 2011-08-30 |
CA2567473A1 (en) | 2005-12-01 |
WO2005112647A3 (en) | 2006-04-27 |
WO2005112631A3 (en) | 2006-03-09 |
BRPI0510827A (en) | 2007-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2567473C (en) | An antimicrobial construction | |
JP4095902B2 (en) | Antibacterial composition | |
CA1337390C (en) | Disinfecting or bleaching tissue | |
ES2252870T3 (en) | BIOCIDE IMPROVED AND BIOCIDE CLOTH. | |
US20060094629A1 (en) | Cleaning composition with time-release cleaning | |
CA2699684A1 (en) | Method for broad spectrum, low residue disinfection with a small droplet hydrogen peroxide-based aerosol | |
JP2019521999A (en) | Preservative composition for wet wipes | |
EP2840893B1 (en) | Active halogen antimicrobial composition and method of use | |
CA3126195C (en) | Virucidal composition for surface disinfection and impregnated wipes | |
CN101175405A (en) | Anti-bacterial composition and anti-bacterial material | |
JP4819681B2 (en) | Biocidal cleaning agent | |
EP3775136A1 (en) | Improved bleaching compositions | |
JPS62283186A (en) | Deodorizing antioxidant composition effective within wide ph region | |
JP4558934B2 (en) | Antibacterial agent | |
EP3982728A1 (en) | Anti-microbial composition and method of using same | |
EP4155373A1 (en) | Disinfectant and protective composition for textiles or similar | |
US3457352A (en) | Method for combating micro-organisms with sodium monochloracetaldehyde bisulfite | |
JPH11313790A (en) | Cleaning implement | |
WO2016191500A1 (en) | Wiper with use indicator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005244642 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005744426 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2567473 Country of ref document: CA Ref document number: 3383/KOLNP/2006 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007517406 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580016271.5 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
ENP | Entry into the national phase |
Ref document number: 2005244642 Country of ref document: AU Date of ref document: 20050518 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005244642 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005744426 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11569417 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0510827 Country of ref document: BR |